Frailty phenotypes and determinants of glucocorticoid-related adverse events in polymyalgia rheumatica at 12 months: a real-life single-center investigation.
Polymyalgia rheumatica (PMR) is a clinically heterogeneous disease with variable trajectories. Although glucocorticoids (GCs) are effective, prolonged exposure carries significant toxicity risks. This study was aimed at exploring whether baseline frailty phenotypes (stratified b…